inyoregister
blacknews
exbulletin
pubmed
KINSHASA / NAIROBI / GENEVA – 10 February 2022 – The ANTICOV platform clinical trial has started the recruitment of participants to test a new promising drug combination, fluoxetine and budesonide, as an early treatment for people affected with mild-to-moderate COVID-19. The ANTICOV trial, currently conducted in 13 […]
ANTICOV: Clinical trial for COVID-19 in low-r Read More »
This report aims to provide detailed insights into the global microplate systems market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information
The decision sparked strong reaction — both negative and positive — from parents and teachers unions, as well as infectious disease specialists, pediatricians, and politicians, underscoring how charged the public
Mass. school mask mandate lifted, but no road map for what comes next Read More »
Now city authorities are facing a backlash. A U.S.-based academic site that had posted their paper, SocArXiv, withdrew it last Friday, charging it was “promoting an unproved medical treatment in
…report published by Grand View Research, In the wake of the COVID-19 pandemic, the demand for dietary supplements and functional foods has soared. Immunity boosting supplements have become mainstream… Source
The World Health Organisation is calling on wealthier nations to donate US$16 billion to a program aimed at providing access to Covid-19 vaccines, treatments and tests in low- and middle-income
WHO asks richer countries to pay US$16b for pandemic plan – Good Articles to Share Read More »
inyoregister
inyoregister
blacknews
exbulletin
pubmed
statnews
usatoday
